Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30...

Approval comes mere days after Apple announces the first of its kind software. Apple's newly announced hearing aid capability is officially the first...

As mounting evidence supports the potential of psychedelic-assisted therapies, the FDA nears a groundbreaking decision: the approval of psilocybin,...

REGN gets FDA nod for Dupixent for a broader population for the indication of chronic rhinosinusitis with nasal polyps.

HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...

HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...

The 3D Urology and Prostate Clinics introduce their groundbreaking 3D Prostate Cancer Targeted Treatment, offering innovative and effective solutions...

September 8, 2024 -- Results from an exploratory analysis of the TROPION-Lung01 Phase III trial showed TROP2 as measured by AstraZeneca’s...

September 8, 2024 -- Results from an exploratory analysis of the TROPION-Lung01 Phase III trial showed TROP2 as measured by AstraZeneca’s...

A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies work together to recruit new...